Asston Pharmaceuticals Limited Press Release Oct 01 2026

1. Receipt, consideration and adoption of the Audited Standalone financial statements of the Company for the financial year ended March 31, 2026 together with the reports of Board of Directors and of the Auditors thereon. 3. Approved appointment of M/s Panchal S K & Associates (Peer Review Certificate No. 018089 and Firm Registration No. 145989W) as Statutory Auditors of the Company (Annexure-B).